EDIT:NASDAQ
Editas Medicine Inc
US$ 2,17
arrow_upward
+1,40%(+0,030) 1D
13 nov, 16:00:01 GMT-5 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor EDIT genereren…
Openen
US$ 2,14
Hoog
US$ 2,21
Laag
US$ 2,01
Beursw.
334,92 mln.
Gem. vol.
2,42 mln.
Volume
2,79 mln.
52 wk hoog
US$ 3,94
52 wk laag
US$ 1,66
WPA
US$ -0,62
Bèta
2,09
Uitstaande aandelen
154,34 mln.
Aantal medewerkers
87
Openen
US$ 2,14
Hoog
US$ 2,21
Laag
US$ 2,01
Beursw.
334,92 mln.
Gem. vol.
2,42 mln.
Volume
2,79 mln.
52 wk hoog
US$ 3,94
52 wk laag
US$ 1,66
WPA
US$ -0,62
Bèta
2,09
Uitstaande aandelen
154,34 mln.
Aantal medewerkers
87
Nieuwsartikelen
Van webbronnen en nieuwspartners
TradingKey
·
5 uur geleden
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
TradingView
·
10 uur geleden
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
24/7 Wall St.
·
6 uur geleden
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Traders Union
·
10 uur geleden
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profiel
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Over Editas Medicine Inc